25.09.2014
Poison oak contact dermatitis
Plant dermatitis
25.09.2014
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
27.09.2019
Interview with Rebecca Naumann: Cryolipolysis devices in comparison
When treating fat cells with cold it depends on the technique: The two leading suppliers in the German-speaking countries rely on certified medical technology. But what are the differences between […]
21.04.2015
The ASCLEPION EFFECT: Spot on for perfect skin
With the concept „THE ASCLEPION EFFECT“ Asclepion Laser Technologies aims to communicate to the users the advatages of laser technology „Made in Germany“ and to increase the well being of […]